Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...
Singapore - MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four s...
Strides Pharma Science (Strides) on Saturday announced that its global arm Strides Pharma Global Pte Singapore has recei...
A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...
Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...
Singapore - The FDA has released new guidance documents aimed at advancing development of generic versio...
Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal ...
Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat...
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mi...
Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a cli...
Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...
Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthr...
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the Ch...
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...
India's Strides Pharma has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limite...
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...
